Can Mirror-Image Chemistry Help Tackle Alzheimer’s? (opens in new tab)
Alzheimer’s disease is a "graveyard" for drug development. The primary culprit—amyloid-beta (Aβ)—is notoriously difficult to target.
Read the original articleAlzheimer’s disease is a "graveyard" for drug development. The primary culprit—amyloid-beta (Aβ)—is notoriously difficult to target.
Read the original article